Manufacturer with High Quality and Competitive Price
Commercial Supply Dapoxetine Hydrochloride and Related Intermediates:
3-Chloropropiophenone CAS: 936-59-4
(S)-3-Amino-3-Phenylpropan-1-ol CAS: 82769-76-4
(S)-3-Amino-3-Phenylpropanoic Acid CAS: 40856-44-8
(R)-Diphenylprolinol CAS: 22348-32-9
(S)-Diphenylprolinol CAS: 112068-01-6
(S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-34-1
(R)-(+)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-33-0
3-Chloro-1-Phenyl-1-Propanol CAS: 18776-12-0
Dapoxetine CAS: 119356-77-3
Dapoxetine Hydrochloride CAS: 129938-20-1
| Chemical Name |
(S)-3-Amino-3-Phenylpropanoic Acid |
| Synonyms |
(S)-β-Phenylalanine; (S)-3-Amino-3-Phenylpropionic Acid |
| CAS Number |
40856-44-8 |
| CAT Number |
RF-CC113 |
| Stock Status |
In Stock, Production Scale Up to Tons |
| Molecular Formula |
C9H11NO2 |
| Molecular Weight |
165.19 |
| Density |
1.198 |
| Brand |
Ruifu Chemical |
| Item |
Specifications |
| Appearance |
White Crystalline Powder |
| Purity |
≥99.0% |
| e.e |
≥99.5% |
| Specific Rotation [α]D20 |
-7.0°~ -9.0°(C=0.3, H2O) |
| Loss on Drying |
≤0.20% |
| Residue on Ignition |
≤0.40% |
| Non-Animal Origin |
Non-Animal Origin |
| Test Standard |
Enterprise Standard |
| Usage |
Chiral Compounds; Pharmaceutical Intermediates |
Package: Bottle, Cardboard Drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-3-Amino-3-Phenylpropanoic Acid (CAS: 40856-44-8) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis.
(S)-3-Amino-3-Phenylpropanoic Acid (CAS: 40856-44-8) can be used in the synthesis of Dapoxetine Hydrochloride (CAS: 129938-20-1).
Dapoxetine Hydrochloride (CAS: 129938-20-1) is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder.